✦ LIBER ✦

A phase I study of intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in patients with previously untreated epithelial ovarian carcinoma or primary peritoneal carcinoma

✍ Scribed by O’Malley, D.; Eisenhauer, E.; McCann, G.; Salani, R.; Backes, F.; Copeland, L.; Fowler, J.; Cohn, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study with an expanded cohort

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase I feasibility trial of carboplatin

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Phase I feasibility study of intraperito

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II clinical trial of bevacizumab w

✍ Tillmanns, Todd D.; Lowe, M. Patrick; Walker, Mark S.; Stepanski, Edward J.; Sch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB

A phase I study with an expanded cohort

✍ Mark A. Morgan; Michael W. Sill; Keiichi Fujiwara; Benjamin Greer; Stephen C. Ru 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB